Ujin Pharma Limited - Company Profile

It is a business services public limited company based in Mumbai, Maharashtra, India, established in 2024.
2024 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Ujin Pharma Limited

Ujin Pharma Limited, a active public limited company, was established on 21 May 2024 in Mumbai, Maharashtra, India. it holds CIN: U46691MH2024PLC425527. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.90 Cr and a paid-up capital of ₹5.88 Cr.

Its leadership includes Jinesh Rasiklal Sheth (Managing Director), Neha Umang Mehta (Director), Umang Ketan Mehta (Director). Past directors included Jinesh Rasiklal Sheth, Neha Umang Mehta, Umang Ketan Mehta. It holds ₹378.80 Cr open charges and no settled loans. It is based at 610/6Th Neelkanth Corporate Park, Kirol Road Vidyavihar West, Mumbai, Maharashtra, 400086.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46691MH2024PLC425527

  • Registration Number

    425527

  • Incorporation Date

    21 May 2024

  • Authorized Capital

    ₹6.90 Cr

  • Paid-Up Capital

    ₹5.88 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.90 Cr
  • Paid Up Capital ₹ 5.88 Cr
  • Company Age 1 Year 9 Months
  • Open Charges ₹ 378.80 Cr
Company report

Ujin Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ujin Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ujin Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Jinesh Rasiklal Sheth Managing Director 21 May 2024 Current
Neha Umang Mehta Director 28 Apr 2025 Current
Umang Ketan Mehta Director 21 May 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Nov 2025 Past
Pramod Abcsdd Additional Director 28 Apr 2025 Past
Pramod Abcsdd Director 25 Nov 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ujin Pharma.
Ujin Pharma revenue growth over time
Ujin Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ujin Pharma?

Unlock access to Ujin Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,788,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 307.80 Cr
  • Yes Bank Limited : 40.00 Cr
  • Axis Bank Limited : 31.00 Cr
Latest Charge Details
Date Lender Amount Status
03 Oct 2025 Others ₹5.00 M Open
13 Aug 2025 Others ₹20.00 Cr Open
25 Apr 2025 Others ₹25.00 Cr Open
22 Jan 2025 Yes Bank Limited ₹40.00 Cr Open
16 Jan 2025 Others ₹35.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Ujin Pharma?

Unlock and access historical data on people associated with Ujin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ujin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ujin Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ujin Pharma
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 75.00 Cr registered on 28 Nov 2024 with Charge ID 101016278 was modified on 15 Nov 2025. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 25.00 Cr registered on 25 Apr 2025 with Charge ID 101088645 was modified on 31 Oct 2025. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 0.50 Cr with Charge ID 101180009 was registered on 03 Oct 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101149425 was registered on 13 Aug 2025. was completed.

  • Director Appointment

    Progress on Neha Umang Mehta was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 10 months 1 day . was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101088645 was registered on 25 Apr 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ujin Pharma Limited?

The CIN of Ujin Pharma Limited is U46691MH2024PLC425527.

Where is Ujin Pharma Limited headquartered?

Ujin Pharma Limited is headquartered at 610/6Th Neelkanth Corporate Park, Kirol Road Vidyavihar West, Mumbai, Maharashtra, 400086.

When was Ujin Pharma Limited incorporated?

Ujin Pharma Limited was incorporated on 21 May 2024.

Who are the current directors of Ujin Pharma Limited?

The current directors of Ujin Pharma Limited are

Is Ujin Pharma Limited a listed company?

Ujin Pharma Limited is unlisted.

What is the capital structure of Ujin Pharma Limited?

The authorized capital of Ujin Pharma Limited is ₹6.90 Cr, and the paid-up capital is ₹5.88 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available